Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference Life Science Investing
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types Life Science Investing
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference Life Science Investing
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference Life Science Investing
Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights Life Science Investing
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA Life Science Investing
